The Latest Breaking News from PTSD

Dog attack-related injuries have skyrocketed in the past decade.

The language of mental ill health is inescapable. Diagnostic terms, such as depression and post-traumatic stress disorder (PTSD), pervade popular culture and saturate the online world. They are the currency of countless news stories and awareness campaigns.

Psychologists have weighed in on Trump’s apparent behavior since the shooting, with one theorizing it’s not PTSD – it’s ‘narcissism’

The FDA just rejected MDMA-assisted therapy for PTSD. What's next for psychedelic drugs in science and everyday life?

The former president has viewed the seven-second clip, in which his right ear was grazed with a bullet, multiple times, according to a Republican source close to his campaign

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is the first such decision issued on a psychedelic drug application.

The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

FDA declines approval for MDMA as PTSD treatment, citing safety and efficacy concerns. Further trials needed.

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD

To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating evidence quality